GUFIC BIOSCIENCES LTD. (GUFICBIO)

NSE: ₹354.35
BSE: ₹356.55
Stock Performance
Corporate Announcements
Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Written Transcript of Earnings Conference Call held on June 01, 2026 at 04:30 PM is attached herewith.

2026-06-05 18:13:02
Corrigendum And Clarification To Intimation Dated May 29, 2026 Regarding Subscription To Shares Of Saraswat Co-Operative Bank Limited

Corrigendum and Clarification to Intimation dated May 29, 2026 regarding Subscription to Shares of Saraswat Co-operative Bank Limited, is attached herewith

2026-06-02 15:27:44
Corrigendum And Clarification To Intimation Dated May 29, 2026 Regarding Subscription To Shares Of Saraswat Co-Operative Bank Limited

Corrigendum and Collaboration to Intimation dated May 29, 2026 regarding Subscription to Shares of Saraswat Co-operative Bank Limited is attached herewith

2026-06-02 14:22:03
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet – Outcome

Intimation for Audio Recording of Earnings Conference Call held on June 01, 2026 at 04:30 p.m. has been attached herewith.

2026-06-01 18:55:57
Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Advertisement of Audited Financial Results (Standalone and Consolidated) for the Quarter and Financial Year ended March 31, 2026 is attached herewith.

2026-05-30 15:17:08
Announcement under Regulation 30 (LODR)-Investor Presentation

Investor Presentation is attached herewith

2026-05-29 23:10:05
Announcement under Regulation 30 (LODR)-Change in Management

Intimation for Re-appointment of Cost Auditor and Appointment of Internal Auditor is attached herewith

2026-05-29 23:00:01
Announcement under Regulation 30 (LODR)-Acquisition

Intimation under Regulation 30 of SEBI Listing Regulations - Further Investment in Saraswat Co-operative Bank Limited is attached herewith.

2026-05-29 22:53:30
Corporate Action-Board approves Dividend

Intimation for recommendation of final dividend for the financial year 2025-2026 is attached herewith

2026-05-29 22:44:27
Results - Audited Financial Results (Standalone And Consolidated) For The Quarter And Financial Year Ended March 31, 2026

Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended March 31, 2026 is attached herewith

2026-05-29 22:34:48

Quarterly Financials

Consolidated Standalone
Particulars Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 214.87 201.78 194.99 202.81 204.18 207.79 205.02 223.72 237.05 231.41 251.82
YOY Revenue Growth % - - - - -4.98% 2.98% 5.14% 10.31% 16.1% 11.37% 22.83%
Other Income 0.33 0.42 0.88 1.25 0.11 1.86 0.39 0.93 2.12 0.79 -1.17
Total Income 215.21 202.20 195.87 204.07 204.29 209.66 205.41 224.65 239.17 232.20 250.65
Total Expenses + 184.26 172.64 168.76 175.96 175.04 183.40 194.89 207.37 216.57 214.48 221.70
Cost of Materials Consumed 95.29 72.92 90.95 72.77 74.93 73.59 122.91 88.52 113.47 99.27 124.07
Employee Benefit Expense 26.78 30.60 29.60 29.05 28.47 33.96 35.57 36.00 37.45 40.09 38.14
Other Expenses 39.62 39.38 42.55 43.25 40.96 45.75 53.40 53.65 57.32 57.32 51.52
Operating Profit 30.61 29.13 26.24 26.85 29.14 24.40 10.13 16.35 20.49 16.93 30.12
OPM % 14.2% 14.4% 13.5% 13.2% 14.3% 11.7% 4.9% 7.3% 8.6% 7.3% 12%
Profit Before Tax + 30.95 29.56 27.12 28.10 29.25 26.26 10.52 17.27 22.60 17.72 28.95
Tax Expense 7.74 7.30 7.07 7.25 7.49 6.96 2.81 4.20 5.78 5.30 7.05
Tax % 25% 24.7% 26.1% 25.8% 25.6% 26.5% 26.7% 24.3% 25.6% 29.9% 24.4%
Profit After Tax 23.21 22.26 20.05 20.86 21.77 19.31 7.72 13.07 16.82 12.42 21.90
EPS (Basic) 2.39 2.23 2.00 2.08 2.17 1.93 0.77 1.30 1.68 1.24 2.18

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024
Revenue from Operations 944.01 819.81 806.67
YOY Revenue Growth % 15.15% 1.63% -
Other Income 2.66 3.63 2.18
Total Income 946.66 823.43 808.84
Total Expenses + 860.12 729.29 693.17
Cost of Materials Consumed 425.33 344.20 341.32
Employee Benefit Expense 151.68 127.05 109.63
Other Expenses 219.81 183.36 161.27
Operating Profit 83.89 90.52 113.49
OPM % 8.9% 11% 14.1%
Profit Before Exceptional 86.55 94.14 115.67
Exceptional Items 0.00 0.00 0.00
Profit Before Tax + 86.55 94.14 115.67
Tax Expense 22.34 24.49 29.54
Tax % 25.8% 26% 25.5%
Profit After Tax 64.21 69.65 86.14
EPS (Basic) 6.40 6.95 8.74

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024
ASSETS
Non-Current Assets + 540.26 544.84 492.06
Property, Plant & Equipment 484.85 499.65 153.27
Capital Work in Progress 22.14 21.82 307.06
Non-Current Investments 1.78 1.78 1.78
Goodwill 0.00 0.00 0.00
Other Intangible Assets 6.16 6.34 5.62
Current Assets + 802.12 624.52 600.48
Inventories 324.47 216.87 200.48
Trade Receivables 297.40 314.61 329.94
Cash and Cash Equivalents 62.19 15.72 1.14
Current Investments 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 664.99 601.08 532.56
Equity Share Capital 10.03 10.03 10.03
Other Equity 654.92 591.05 522.53
Non-Current Liabilities 159.54 180.73 187.93
Current Liabilities 517.85 387.56 372.05
Total Liabilities 677.39 568.29 559.98

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024
Cash from Operating Activities 44.97 122.57 -7.46
Cash from Investing Activities -30.96 -70.78 -102.39
Cash from Financing Activities 32.46 -37.20 82.38
Net Increase/Decrease in Cash 46.46 14.59 -27.47